AQR Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $429M | Buy |
7,676,541
+989,625
| +15% | +$57.7M | 0.2% | 115 |
|
|
2025
Q4 | $395M | Buy |
6,686,916
+754,807
| +13% | +$41.1M | 0.21% | 112 |
|
|
2025
Q3 | $321M | Buy |
5,932,109
+351,536
| +6% | +$20.1M | 0.21% | 108 |
|
|
2025
Q2 | $306M | Buy |
5,580,573
+2,654,768
| +91% | +$156M | 0.25% | 79 |
|
|
2025
Q1 | $204M | Buy |
2,925,805
+1,642,206
| +128% | +$110M | 0.21% | 112 |
|
|
2024
Q4 | $84.4M | Buy |
1,283,599
+685,099
| +114% | +$45.9M | 0.11% | 246 |
|
|
2024
Q3 | $42.1M | Buy |
598,500
+543,128
| +981% | +$45.4M | 0.06% | 422 |
|
|
2024
Q2 | $4.56M | Buy |
55,372
+32,709
| +144% | +$2.72M | 0.01% | 1066 |
|
|
2024
Q1 | $1.98M | Sell |
22,663
-34,410
| -60% | -$3.08M | ﹤0.01% | 1418 |
|
|
2023
Q4 | $5.5M | Sell |
57,073
-31,984
| -36% | -$2.83M | 0.01% | 905 |
|
|
2023
Q3 | $7.88M | Sell |
89,057
-86,329
| -49% | -$7.68M | 0.02% | 744 |
|
|
2023
Q2 | $15.2M | Buy |
175,386
+99,686
| +132% | +$9.38M | 0.03% | 550 |
|
|
2023
Q1 | $7.3M | Buy |
75,700
+25,505
| +51% | +$2.64M | 0.02% | 754 |
|
|
2022
Q4 | $5.1M | Buy |
50,195
+21,108
| +73% | +$1.98M | 0.01% | 879 |
|
|
2022
Q3 | $2.47M | Buy |
29,087
+21,038
| +261% | +$1.87M | 0.01% | 1113 |
|
|
2022
Q2 | $663K | Buy |
8,049
+1,939
| +32% | +$154K | ﹤0.01% | 1576 |
|
|
2022
Q1 | $471K | Buy |
6,110
+3,809
| +166% | +$319K | ﹤0.01% | 1840 |
|
|
2021
Q4 | $203K | Sell |
2,301
-1,054
| -31% | -$87K | ﹤0.01% | 2086 |
|
|
2021
Q3 | $259K | Sell |
3,355
-6,997
| -68% | -$552K | ﹤0.01% | 2079 |
|
|
2021
Q2 | $860K | Buy |
10,352
+3,001
| +41% | +$238K | ﹤0.01% | 1649 |
|
|
2021
Q1 | $555K | Sell |
7,351
-23,264
| -76% | -$1.9M | ﹤0.01% | 1791 |
|
|
2020
Q4 | $2.63M | Sell |
30,615
-76,861
| -72% | -$6.09M | ﹤0.01% | 1034 |
|
|
2020
Q3 | $8.18M | Buy |
107,476
+93,421
| +665% | +$9.45M | 0.01% | 671 |
|
|
2020
Q2 | $1.73M | Buy |
14,055
+6,850
| +95% | +$681K | ﹤0.01% | 1220 |
|
|
2020
Q1 | $595K | Sell |
7,205
-7,789
| -52% | -$671K | ﹤0.01% | 1527 |
|
|
2019
Q4 | $1.26M | Buy |
+14,994
| New | +$1.13M | ﹤0.01% | 1441 |
|
|
2016
Q4 | – | Sell |
-12,718
| Closed | -$1.18M | – | 2232 |
|
|
2016
Q3 | $1.18M | Buy |
+12,718
| New | +$1.2M | ﹤0.01% | 1664 |
|
|
2016
Q2 | – | Sell |
-10,593
| Closed | -$874K | – | 2201 |
|
|
2016
Q1 | $874K | Sell |
10,593
-174,705
| -94% | -$14.2M | ﹤0.01% | 1630 |
|
|
2015
Q4 | $19.4M | Sell |
185,298
-33,306
| -15% | -$3.48M | 0.03% | 554 |
|
|
2015
Q3 | $23M | Sell |
218,604
-92,080
| -30% | -$12.3M | 0.05% | 447 |
|
|
2015
Q2 | $42.5M | Buy |
310,684
+274,190
| +751% | +$34M | 0.08% | 285 |
|
|
2015
Q1 | $4.55M | Buy |
36,494
+32,400
| +791% | +$3.43M | 0.01% | 807 |
|
|
2014
Q4 | $370K | Sell |
4,094
-36,477
| -90% | -$3.03M | ﹤0.01% | 2100 |
|
|
2014
Q3 | $2.93M | Sell |
40,571
-57,300
| -59% | -$3.77M | 0.01% | 1067 |
|
|
2014
Q2 | $6.09M | Buy |
97,871
+73,300
| +298% | +$4.43M | 0.02% | 818 |
|
|
2014
Q1 | $1.68M | Sell |
24,571
-55,600
| -69% | -$4.1M | 0.01% | 1409 |
|
|
2013
Q4 | $5.63M | Buy |
80,171
+62,771
| +361% | +$4.26M | 0.02% | 827 |
|
|
2013
Q3 | $1.26M | Buy |
17,400
+2,600
| +18% | +$173K | ﹤0.01% | 1545 |
|
|
2013
Q2 | $826K | Buy |
+14,800
| New | +$922K | ﹤0.01% | 1672 |
|
Other funds holding BMRN
VCM
VPM
